Communiqués T2 Biosystems, Inc.

Actions

TTOO

US89853L3024

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
5,14 ^USD	+1,58 %		+3,84 %	-18,09 %

15/05	Mise à jour sectorielle : Les actions du secteur de la santé progressent mercredi en fin d'après-midi	MT
15/05	Les actions de T2 Biosystems augmentent après que CRG Servicing ait augmenté sa participation	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements	22/05	AQ
Treatment.com AI Inc (CSE: TRUE) Partners with Novus Health to Support Over 1.5 Million Members and Families	16/05	AQ
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules	15/05	AQ
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock	14/05	AQ
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease	07/05	AQ
T2 Biosystems: Q1 Earnings Snapshot	06/05	AQ
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor	06/05	AQ
T2 Biosystems Announces First Quarter 2024 Financial Results	06/05	AQ
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity	06/05	AQ
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	24/04	AQ
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	11/04	AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	28/03	AQ
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	20/03	AQ
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	19/03	AQ
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	18/03	AQ
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	12/03	AQ
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	15/02	AQ
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	15/02	AQ
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	15/02	AQ
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel	12/02	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués T2 Biosystems, Inc.

Actions

TTOO

US89853L3024

Communiqués

Filtres